154.33
0.62%
-0.96
プレマーケット:
155.94
1.61
+1.04%
前日終値:
$155.29
開ける:
$155.37
24時間の取引高:
543.64K
Relative Volume:
0.76
時価総額:
$17.23B
収益:
$9.35B
当期純損益:
$840.00M
株価収益率:
23.17
EPS:
6.66
ネットキャッシュフロー:
$875.00M
1週間 パフォーマンス:
-1.02%
1か月 パフォーマンス:
+2.35%
6か月 パフォーマンス:
+12.34%
1年 パフォーマンス:
+15.25%
Quest Diagnostics Inc Stock (DGX) Company Profile
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-08-28 | 再開されました | Evercore ISI | In-line |
2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
2024-02-26 | 開始されました | Leerink Partners | Market Perform |
2024-02-07 | アップグレード | Jefferies | Hold → Buy |
2024-01-03 | 開始されました | Barclays | Equal Weight |
2023-12-12 | アップグレード | BofA Securities | Neutral → Buy |
2023-06-29 | 開始されました | Piper Sandler | Neutral |
2023-05-02 | ダウングレード | BofA Securities | Buy → Neutral |
2023-04-03 | アップグレード | Citigroup | Sell → Neutral |
2023-01-23 | 開始されました | Evercore ISI | In-line |
2022-11-17 | ダウングレード | Citigroup | Neutral → Sell |
2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
2022-04-04 | ダウングレード | Citigroup | Buy → Neutral |
2022-02-23 | ダウングレード | UBS | Buy → Neutral |
2022-02-02 | ダウングレード | Jefferies | Buy → Hold |
2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
2021-05-04 | アップグレード | UBS | Neutral → Buy |
2021-03-12 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-10-21 | アップグレード | Argus | Hold → Buy |
2020-07-29 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
2020-06-09 | アップグレード | Wells Fargo | Underweight → Equal Weight |
2020-06-02 | アップグレード | Deutsche Bank | Hold → Buy |
2020-04-28 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2020-03-27 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2020-01-08 | 開始されました | Wells Fargo | Underweight |
2020-01-07 | ダウングレード | Barclays | Overweight → Equal Weight |
2019-12-19 | アップグレード | BofA/Merrill | Underperform → Neutral |
2019-07-15 | ダウングレード | Goldman | Neutral → Sell |
2019-04-02 | アップグレード | Jefferies | Hold → Buy |
2019-03-18 | 再開されました | Credit Suisse | Neutral |
2019-01-31 | ダウングレード | Argus | Buy → Hold |
2019-01-17 | 開始されました | UBS | Neutral |
2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
2018-12-03 | ダウングレード | BofA/Merrill | Buy → Neutral |
2018-11-30 | ダウングレード | Goldman | Buy → Neutral |
すべてを表示
Quest Diagnostics Inc (DGX) 最新ニュース
New York State Teachers Retirement System Trims Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
DGX (Quest Diagnostics) PE Ratio : 20.87 (As of Nov. 02, 2024) - GuruFocus.com
Quest Diagnostics Inc. stock rises Friday, still underperforms market - MarketWatch
Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by State of Alaska Department of Revenue - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Holdings Lowered by Assenagon Asset Management S.A. - MarketBeat
Quest Diagnostics (NYSE:DGX) Upgraded at StockNews.com - MarketBeat
Quest Diagnostics' SVP sells shares worth $278,525 By Investing.com - Investing.com Canada
Quest Diagnostics' SVP sells shares worth $278,525 - Investing.com India
abrdn plc Has $71.50 Million Stock Position in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock rises Tuesday, still underperforms market - MarketWatch
Quest Diagnostics (NYSE:DGX) PT Raised to $165.00 - MarketBeat
DekaBank Deutsche Girozentrale Has $115.62 Million Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Director Gregg Vicky B increased direct ownership by 0.42% to 18,045 units (SEC Form 4) - Quantisnow
SVP & Chief Commercial Officer Delaney Mark E increased direct ownership by 0.08% to 5,023 units (SEC Form 4) - Quantisnow
Quest Diagnostics Incorporated (NYSE:DGX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance
FY2025 EPS Forecast for Quest Diagnostics Reduced by Analyst - MarketBeat
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Raymond James & Associates Purchases 14,899 Shares of Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Mizuho Boosts Quest Diagnostics (NYSE:DGX) Price Target to $174.00 - MarketBeat
Quest Diagnostics: Organic Growth Leads To Q3 Earnings Beat (NYSE:DGX) - Seeking Alpha
Quest Diagnostics (NYSE:DGX) Stock Rating Upgraded by Baird R W - MarketBeat
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare - Yahoo Finance
Quest Diagnostics to launch avian flu testing this month By Investing.com - Investing.com Canada
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - Yahoo Finance
Quest Diagnostics (NYSE:DGX) Cut to Hold at StockNews.com - MarketBeat
Ord Minnett rates SHL as Lighten - Marketscreener.com
Quest Diagnostics Inc. stock outperforms competitors despite losses on the day - MarketWatch
My Quest Story – Martha Baer - StockTitan
Quest upgraded to outperform by Baird, sector momentum cited - MSN
Quest Diagnostics (NYSE:DGX) Sets New 12-Month High After Strong Earnings - MarketBeat
UBS Group Boosts Quest Diagnostics (NYSE:DGX) Price Target to $166.00 - MarketBeat
Quest Diagnostics stock hits 52-week high of $159.46 By Investing.com - Investing.com Canada
Quest Diagnostics (NYSE:DGX) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Quest Diagnostics set to launch a rapid lab test to detect avian influenza A H5 virus - Seeking Alpha
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2024 Earnings Call Transcript - Insider Monkey
US lab operator Quest Diagnostics to launch bird flu test at end of October - Reuters.com
Quest Diagnostics (NYSE:DGX) Rating Increased to Outperform at Robert W. Baird - MarketBeat
Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development - PR Newswire
Quest Diagnostics: Q3 Earnings Snapshot - The Advocate
Why Investors Shouldn't Be Surprised By Quest Diagnostics Incorporated's (NYSE:DGX) P/E - Simply Wall St
Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Quest Diagnostics Thrives With Strong Demand Pushing Profit Above Expectations - Finimize
Earnings call: Quest Diagnostics reports robust Q3 growth, eyes M&A By Investing.com - Investing.com Canada
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday - MSN
Quest Diagnostics (NYSE:DGX) Shares Gap UpShould You Buy? - MarketBeat
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025 - Benzinga
Quest Diagnostics (NYSE:DGX) Releases FY 2024 Earnings Guidance - MarketBeat
Quest Diagnostics beats quarterly results estimates on diagnostic test demand - Reuters
Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates - Yahoo Finance
Copeland Capital Management LLC Increases Stock Holdings in Quest Diagnostics Incorporated (NYSE:DGX) - MarketBeat
Quest Diagnostics Inc (DGX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):